Explore the complexities of tauopathies and how new research could change their diagnosis and treatment approaches.

In the quest to cure Alzheimer's, the protein known as beta-amyloid has long taken center stage, driving development of a ...

Researchers at the University of Texas Medical Branch recently discovered a significant advancement in the fight against ...

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

Scientists discovered why some neurons resist tau toxicity, identifying CRL5SOCS4 as a crucial defense and linking ...

In Alzheimer’s disease and other dementias, a protein called tau can pile up inside brain cells and form toxic clumps. Those ...

New research by UCLA Health and UC San Francisco has uncovered why certain brain cells are more resilient than others to the buildup of a toxic protein that is a hallmark of Alzheimer's disease and ...

Stopping Alzheimer’s may begin with dissolving tiny tau protein clusters before damage takes hold.

Researchers found a "garbage man" enzyme that tags toxic clumps of proteins in the brain for removal, and saw a correlation ...

The Rainwater Charitable Foundation (RCF), one of the largest independent funders of neurodegenerative research that enables ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...